Physiological Levels of Thrombospondin-1 Decrease NO-dependent Vasodilation in Coronary Microvessels from Aged Rats
Overview
Physiology
Authors
Affiliations
Aging and cardiovascular disease are associated with the loss of nitric oxide (NO) signaling and a decline in the ability to increase coronary blood flow reserve (CFR). Thrombospondin-1 (Thbs-1), through binding of CD47, has been shown to limit NO-dependent vasodilation in peripheral vascular beds via formation of superoxide (O2 (-)). The present study tests the hypothesis that, similar to the peripheral vasculature, blocking CD47 will improve NO-mediated vasoreactivity in coronary arterioles from aged individuals, resulting in improved CFR. Isolated coronary arterioles from young (4 mo) or old (24 mo) female Fischer 344 rats were challenged with the NO donor, DEA-NONO-ate (1 × 10(-7) to 1 × 10(-4) M), and vessel relaxation and O2 (-) production was measured before and after Thbs-1, αCD47, and/or Tempol and catalase exposure. In vivo CFR was determined in anesthetized rats (1-3% isoflurane-balance O2) via injected microspheres following control IgG or αCD47 treatment (45 min). Isolated coronary arterioles from young and old rats relax similarly to exogenous NO, but addition of 2.2 nM Thbs-1 inhibited NO-mediated vasodilation by 24% in old rats, whereas young vessels were unaffected. Thbs-1 increased O2 (-) production in coronary arterioles from rats of both ages, but this was exaggerated in old rats. The addition of CD47 blocking antibody completely restored NO-dependent vasodilation in isolated arterioles from aged rats and attenuated O2 (-) production. Furthermore, αCD47 treatment increased CFR from 9.6 ± 9.3 (IgG) to 84.0 ± 23% in the left ventricle in intact, aged animals. These findings suggest that the influence of Thbs-1 and CD47 on coronary perfusion increases with aging and may be therapeutically targeted to reverse coronary microvascular dysfunction.
Functional, Structural and Proteomic Effects of Ageing in Resistance Arteries.
Jensen L Int J Mol Sci. 2024; 25(5).
PMID: 38473847 PMC: 10932216. DOI: 10.3390/ijms25052601.
Isenberg J, Montero E Clin Transl Med. 2024; 14(2):e1584.
PMID: 38362603 PMC: 10870051. DOI: 10.1002/ctm2.1584.
Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction.
Zhang Z, Li X, He J, Wang S, Wang J, Liu J J Thromb Thrombolysis. 2023; 56(3):388-397.
PMID: 37466848 DOI: 10.1007/s11239-023-02862-2.
Matricellular proteins in atherosclerosis development.
Pervaiz N, Kathuria I, Aithabathula R, Singla B Matrix Biol. 2023; 120:1-23.
PMID: 37086928 PMC: 10225360. DOI: 10.1016/j.matbio.2023.04.003.
Yao M, Ganguly S, Shin J, Elbayoumi T Methods Protoc. 2021; 4(4).
PMID: 34698263 PMC: 8544428. DOI: 10.3390/mps4040074.